Anbio Biotechnology Class... (NNNN)
NASDAQ: NNNN
· Real-Time Price · USD
6.50
0.07 (1.09%)
At close: May 05, 2025, 3:59 PM
6.72
3.38%
After-hours: May 05, 2025, 03:58 PM EDT
1.09% (1D)
| Bid | 6.14 |
| Market Cap | 285.29M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | 0.05 |
| PE Ratio (ttm) | 130 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 6.89 |
| Volume | 18,138 |
| Avg. Volume (20D) | 151,609 |
| Open | 6.60 |
| Previous Close | 6.43 |
| Day's Range | 6.30 - 6.72 |
| 52-Week Range | 5.18 - 7.82 |
| Beta | 0.00 |
About NNNN
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves o...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Feb 19, 2025
Employees NaN
Stock Exchange NASDAQ
Ticker Symbol NNNN
Website https://www.anbio.com
2 months ago · seekingalpha.com
U.S. IPO Weekly Recap: IPO Calendar Slows Down With Small ListingsThe calendar slowed down this past week, with only small listings in the US. There was one sizable filing this past week - AIRO Group Holdings. No IPOs are currently scheduled to list in the week ahea...